Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease. [electronic resource] by
- Bachmann, K
- Sullivan, T J
- Reese, J H
- Jauregui, L
- Miller, K
- Scott, M
- Yeh, K C
- Stepanavage, M
- King, J D
- Schwartz, J
Producer: 19950929
In:
Journal of clinical pharmacology vol. 35
Availability: No items available.
|
|
5.
|
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. [electronic resource] by
- Rogers, J D
- Zhao, J
- Liu, L
- Amin, R D
- Gagliano, K D
- Porras, A G
- Blum, R A
- Wilson, M F
- Stepanavage, M
- Vega, J M
Producer: 19991110
In:
Clinical pharmacology and therapeutics vol. 66
Availability: No items available.
|
|
6.
|
Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia. [electronic resource] by
- Nussbaum, S R
- Warrell, R P
- Rude, R
- Glusman, J
- Bilezikian, J P
- Stewart, A F
- Stepanavage, M
- Sacco, J F
- Averbuch, S D
- Gertz, B J
Producer: 19930826
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 11
Availability: No items available.
|
|
7.
|
Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers. [electronic resource] by
- Lee, Y
- Conroy, J A
- Stepanavage, M E
- Mendel, C M
- Somers, G
- McLoughlin, D A
- Olah, T V
- De Smet, M
- Keymeulen, B
- Rogers, J D
Producer: 19990610
In:
British journal of clinical pharmacology vol. 47
Availability: No items available.
|
|
8.
|
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. [electronic resource] by
- Stein, E A
- Davidson, M H
- Dobs, A S
- Schrott, H
- Dujovne, C A
- Bays, H
- Weiss, S R
- Melino, M R
- Stepanavage, M E
- Mitchel, Y B
Producer: 19980901
In:
The American journal of cardiology vol. 82
Availability: No items available.
|
|
9.
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. [electronic resource] by
- Ose, L
- Davidson, M H
- Stein, E A
- Kastelein, J J
- Scott, R S
- Hunninghake, D B
- Campodonico, S
- Insull, W
- Escobar, I D
- Schrott, H G
- Stepanavage, M E
- Wu, M
- Tate, A C
- Melino, M R
- Mercuri, M
- Mitchel, Y B
Producer: 20000317
In:
Clinical cardiology vol. 23
Availability: No items available.
|
|
10.
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. [electronic resource] by
- Davidson, M H
- Stein, E A
- Hunninghake, D B
- Ose, L
- Dujovne, C A
- Insull, W
- Bertolami, M
- Weiss, S R
- Kastelein, J J
- Scott, R S
- Campodónico, S
- Escobar, I D
- Schrott, H G
- Bays, H
- Stepanavage, M E
- Wu, M
- Tate, A C
- Melino, M R
- Kush, D
- Mercuri, M
- Mitchel, Y B
Producer: 20010426
In:
Nutrition, metabolism, and cardiovascular diseases : NMCD vol. 10
Availability: No items available.
|